Literature DB >> 19003636

Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia.

Christine A R Lok1, Joris A M Van Der Post, Ian L Sargent, Chi M Hau, Augueste Sturk, Kees Boer, Rienk Nieuwland.   

Abstract

BACKGROUND: Microparticles (MP) are pro-coagulant vesicles derived from various cells. Evidence is accumulating that MP are of pathophysiological relevance in autoimmune, cardiovascular, and thromboembolic diseases and inflammatory disorders. Therefore, their role in the development of preeclampsia was investigated and MP from preeclamptic patients influenced endothelial-dependent vasodilatation. Knowledge about changes in circulating MP numbers during pregnancy and preeclampsia is lacking. We determined this longitudinally and investigated whether these numbers related to the severity of preeclampsia.
METHODS: Samples were obtained from pregnant women and preeclamptic patients during pregnancy and postpartum. MP were isolated and studied by flow cytometry.
RESULTS: During pregnancy, MP were decreased at 12 weeks gestation and then returned to postpartum values. In patients with preeclampsia, MP numbers were reduced at 28 and 36 weeks (both p = 0.04). Monocyte-derived MP were elevated in preeclampsia at 28 (p = 0.007), 32 (p = 0.02), and 36 weeks (p = 0.01), as were erythrocyte-derived MP at 28 weeks (p = 0.04). Placenta-derived MP increased in pregnancy and preeclampsia. During pregnancy, a correlation was present between placenta-derived MP and systolic blood pressure (r = 0.33, p = 0.015). No other correlations were found.
CONCLUSIONS: During pregnancy, numbers of MP initially decrease and subsequently normalize. Placenta-derived MP increase, possibly because of placental growth. In preeclampsia, reduced numbers of PMP are due to decreased platelet counts. Increased numbers of monocyte-derived MP reflect monocyte activation, which may be an expression of the systemic inflammation in preeclampsia. Lack of correlation between numbers of MP and severity of preeclampsia suggests that MP numbers alone do not explain the reported vascular effects of MP.

Entities:  

Mesh:

Year:  2008        PMID: 19003636     DOI: 10.1080/10641950801955733

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  34 in total

Review 1.  Flow cytometric analysis of circulating microparticles in plasma.

Authors:  Aaron F Orozco; Dorothy E Lewis
Journal:  Cytometry A       Date:  2010-06       Impact factor: 4.355

2.  Effects of progesterone and estradiol sex hormones on the release of microparticles by RAW 264.7 macrophages stimulated by Poly(I:C).

Authors:  David S Pisetsky; Diane M Spencer
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

Review 3.  Placental extracellular vesicles and feto-maternal communication.

Authors:  M Tong; L W Chamley
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

Review 4.  Microparticle analysis in disorders of hemostasis and thrombosis.

Authors:  Micah J Mooberry; Nigel S Key
Journal:  Cytometry A       Date:  2015-02-20       Impact factor: 4.355

Review 5.  Association of microparticles and preeclampsia.

Authors:  Fabiana K Marques; Fernanda M F Campos; Lirlândia P Sousa; Andréa Teixeira-Carvalho; Luci M S Dusse; Karina B Gomes
Journal:  Mol Biol Rep       Date:  2013-05-06       Impact factor: 2.316

6.  Systemic inflammatory stimulation by microparticles derived from hypoxic trophoblast as a model for inflammatory response in preeclampsia.

Authors:  Seung Mi Lee; Roberto Romero; You Jeong Lee; In Sook Park; Chan-Wook Park; Bo Hyun Yoon
Journal:  Am J Obstet Gynecol       Date:  2012-06-29       Impact factor: 8.661

Review 7.  Extracellular vesicles and their immunomodulatory functions in pregnancy.

Authors:  Soumyalekshmi Nair; Carlos Salomon
Journal:  Semin Immunopathol       Date:  2018-04-03       Impact factor: 9.623

8.  Placental release of distinct DNA-associated micro-particles into maternal circulation: reflective of gestation time and preeclampsia.

Authors:  A F Orozco; C J Jorgez; W D Ramos-Perez; E J Popek; X Yu; C A Kozinetz; F Z Bischoff; D E Lewis
Journal:  Placenta       Date:  2009-08-18       Impact factor: 3.481

9.  The placenta in preeclampsia.

Authors:  James M Roberts; C Escudero
Journal:  Pregnancy Hypertens       Date:  2012-04-01       Impact factor: 2.899

Review 10.  Role of the syncytium in placenta-mediated complications of preeclampsia.

Authors:  Seth Guller
Journal:  Thromb Res       Date:  2009-06-16       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.